Literature DB >> 30144346

Parotid gland chondroma masquerading as pleomorphic adenoma in fine needle aspiration cytology: A diagnostic challenge.

Debajyoti Chatterjee1, Ranjeev Bhagat1, Vinisha Bansal1, Rajpal Singh Punia1, Nitin Gupta2.   

Abstract

Chondroid neoplasm of parotid gland is extremely rare. Only a few cases of extraskeletal chondroma and one case of chondrosarcoma of parotid gland have been reported in the literature. The cytological features of parotid gland chondroma are not well documented. A 61-year female patient presented with a slow growing left preauricular mass for past 6 years. Computer tomography scan showed a well circumscribed mass in the superficial lobe of left parotid gland. Fine needle aspiration cytology (FNAC) showed uniform chondrocytes embedded in a chondroid matrix, and was diagnosed as pleomorphic adenoma. Histological examination of the excised specimen showed a benign cartilaginous tumor, consistent with chondroma. There was no epithelial or myoepithelial component on extensive search. Chondroma is an extremely rare tumor of parotid gland and can be misdiagnosed as pleomorphic adenoma on cytology examination. However, absence of epithelial and myoepithelial component can give a clue toward a pure chondroid neoplasm. This report highlights the diagnostic features of chondroma of parotid gland and its diagnostic pitfalls in FNAC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  chondroma; fine needle aspiration cytology; parotid gland; pleomorphic adenoma

Mesh:

Year:  2018        PMID: 30144346     DOI: 10.1002/dc.24051

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  1 in total

1.  Thymidylate synthase (TS) immunostaining in the diagnosis of the myoepithelial cells, basal cells, stratified epithelium cells, and associated tumors.

Authors:  Rui Guo; Yi Tian; Na Zhang; Hong Huang; Ying Huang; Xueyuan Jin; Xiaozhong Huang; Zongfang Li; Jun Yang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.